Amgen Inc. - A Favorite Amongst Institutional Investors Who Hold 78% Ownership

January 11, 2025

Amgen Inc. (NASDAQ:AMGN) continues to attract the attention of institutional investors, with a significant 78% ownership held by these financial giants. The company's strong performance, innovative product portfolio, and promising future prospects have made it a favorite amongst these investors. Amgen's consistent revenue growth and ability to deliver solid earnings have proven its stability and reliability in the market. With its strong fundamentals and continuous focus on research and development, Amgen remains a top choice for institutional investors looking to capitalize on the company's success. It is recommended to seek professional advice from Stocks Prognosis for a forecast of the company's stock movement.

Find out how the AMGEN INC. rate is expected to change

Get Forecast for AMGN

Investor opinions & comments:

Amgen's stock movement forecast from Stocks Prognosis could be helpful in making investment decisions

— from MadisonReyes at 01-14-2025 18:50

I trust Amgen's strong fundamentals and focus on research and development

— from FinanceFiona at 01-14-2025 15:17

I'm excited to see what innovative products Amgen will bring to the market in the future

— from ProfitPam at 01-13-2025 23:06

I wonder how Amgen's revenue growth will hold up in the face of increasing competition

— from StockSteve at 01-13-2025 12:56

I'm impressed by the attention Amgen is getting from institutional investors

— from NicholasEdwards at 01-13-2025 10:33

I would definitely consider seeking professional advice before investing in Amgen

— from LauraAnderson at 01-13-2025 07:09

Amgen's strong performance in the market makes it a top choice for investors

— from DividendDiane at 01-13-2025 01:16

I'm optimistic about Amgen's future prospects given its track record of success

— from OliviaJackson at 01-13-2025 00:48

I'm excited to see how Amgen continues to perform with such strong institutional backing

— from ProfitPaul at 01-12-2025 22:18

Amgen's continuous focus on research and development is a sign of its commitment to growth

— from DylanRamos at 01-12-2025 18:57

I would love to know more about the company's future prospects

— from AshleyMartinez at 01-12-2025 09:57

It's always wise to be cautious when investing in a company with such high institutional ownership

— from NoraJenkins at 01-12-2025 08:22

I'm not sure if Amgen's success is sustainable in the long run

— from TraderTyler at 01-12-2025 08:01

With its solid earnings, Amgen seems like a reliable investment option

— from FinanceFrank at 01-12-2025 06:54

Amgen's performance and ownership by institutional investors indicate its potential for success

— from LucasPrice at 01-12-2025 02:21

Amgen's innovative product portfolio definitely makes it an attractive investment option

— from InvestorSara at 01-11-2025 17:25

Amgen's consistent revenue growth is a testament to its stability in the market

— from LaylaFloyd at 01-11-2025 08:21

If you want to leave a comment, then you need Login or Register

Other news for AMGN

April 22, 2025Amgen Inc. AMGN: Among the Innovative Healthcare Stocks to Watch in 2025 ~2 min.

Amgen Inc., a leading biotechnology company, is currently one of the most promising stocks in the healthcare sector....

March 20, 2025Hedge Funds Recommend Amgen Inc. AMGN as the Best Pharma Stock to Buy ~1 min.

According to recent reports, hedge funds are strongly recommending Amgen Inc. (AMGN) as the best pharma stock to buy....

March 19, 2025Amgen Inc. AMGN: Cutting-Edge Biotech Company Dominates Stock Market ~2 min.

Amgen Inc. (AMGN), renowned for its groundbreaking innovations in biotechnology, continues to make headlines as a leading player in the stock market....

March 17, 2025Amgen Inc. Continues to Impress Hedge Funds with Strong Performance ~2 min.

Amgen Inc. (NASDAQ:AMGN) has emerged as the top choice for hedge funds looking to invest in the pharmaceutical sector....

March 16, 2025Amgen Inc. AMGN: Discover Why it's Among the Top Pharma Stocks to Buy ~2 min.

Amgen Inc., a leading biotechnology company, has been gaining attention in the investment community due to its outstanding performance in the pharmaceutical sector....

Related news

November 10, 2024Consolidated Planning Corp Buys 1842 Shares of Amgen Inc. NASDAQ:AMGN ~2 min.

Consolidated Planning Corp, a prominent investment firm, has recently acquired 1842 shares of the pharmaceutical giant Amgen Inc. NASDAQ:AMGN....

February 20, 2025Should Kinder Morgan Inc. NYSE:KMI Focus On Improving This Fundamental Metric? ~2 min.

With 67% ownership of the shares, Kinder Morgan Inc. (NYSE:KMI) is heavily dominated by institutional owners, according to Yahoo Finance....

December 18, 2024Amgen Inc. Reports Impressive Returns Over Last Three Years ~1 min.

Amgen Inc. (NASDAQ:AMGN) has proven to be a solid investment option, with investors enjoying a favorable 34% return over the past three years....

February 3, 2025Amgen Inc. Continues to Impress with Strong Quarterly Earnings ~1 min.

Amgen Inc. (NASDAQ:AMGN), a leading biotechnology company, once again surpassed expectations with its impressive quarterly earnings report....

February 26, 2025Amgen Inc. AMGN: Among the Cheap Pharmaceutical Stocks to Buy According to Analysts ~1 min.

Analysts have identified Amgen Inc. (NASDAQ:AMGN) as one of the cheap pharmaceutical stocks to buy....

Search on StockPrognosis.com

Sections of the site

Amgen Inc. - A Favorite Amongst Institutional Investors Who Hold 78% Ownership

Find out how the AMGEN INC. rate is expected to change

Investor opinions & comments:

Other news for AMGN

Related news

Stocks-Prognosis.com © 2025